| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/08/1991 | CA2066240A1 Interleukin-4 receptors |
| 03/08/1991 | CA2024697A1 Protein having anticoagulant properties |
| 03/07/1991 | WO1991002819A1 Recombinant japanese encephalitis molecules and methods of use therefor |
| 03/07/1991 | WO1991002810A1 Nmda oxidizing agents for protecting neurons from injury |
| 03/07/1991 | WO1991002807A1 Production of biologically active insulin-like growth factor i from high expression host cell systems |
| 03/07/1991 | WO1991002805A2 Recombinant retroviruses delivering vector constructs to target cells |
| 03/07/1991 | WO1991002798A2 t-PA MUTANT GK1L |
| 03/07/1991 | WO1991002796A1 Cystic fibrosis gene |
| 03/07/1991 | WO1991002793A1 Cardiomyopathic transgenic non-human mammal |
| 03/07/1991 | WO1991002788A1 Herpes simplex virus type 1 mutant |
| 03/07/1991 | WO1991002756A1 Prohormone cleavage site blocking antibody |
| 03/07/1991 | WO1991002754A1 Fusion proteins comprising gm-csf and il-3 |
| 03/07/1991 | WO1991002753A1 Anticoagulant protein |
| 03/07/1991 | WO1991002751A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 03/07/1991 | WO1991002749A1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP) AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF |
| 03/07/1991 | WO1991002748A1 Rubella e1 peptides |
| 03/07/1991 | WO1991002746A1 Therapeutic peptides |
| 03/07/1991 | WO1991002745A1 Therapeutic peptides |
| 03/07/1991 | WO1991002541A1 Detection and treatment of infections with immunoconjugates |
| 03/07/1991 | WO1991002540A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 03/07/1991 | WO1991002539A1 Method of obtaining, from casein beta, biologically active peptide enriched fractions, and peptide fractions thus obtained |
| 03/07/1991 | WO1991002537A1 Synthetic peptides that enhance cell binding |
| 03/07/1991 | WO1991002536A1 Compositions and methods for detection and treatment of epstein-barr virus infection and immune disorders |
| 03/07/1991 | WO1991002533A1 Topical compositions containing lycd and other topically active medicinal ingredients |
| 03/07/1991 | WO1991002532A2 Method for stimulating fibrinolytic effect |
| 03/07/1991 | WO1991002531A1 Method for the modulation of haemopoiesis in a mammal |
| 03/07/1991 | CA2065017A1 Peptides from gtpase-activating protein (gap) and diagnostic and therapeutic use thereof |
| 03/07/1991 | CA2064896A1 Therapeutic peptides |
| 03/07/1991 | CA2039175A1 Therapeutic peptides |
| 03/06/1991 | EP0415731A2 Novel entities for cancer therapy |
| 03/06/1991 | EP0415693A1 Composition and method for selective enhancement of opiate activity and reduction of opiate tolerance and dependence |
| 03/06/1991 | EP0415321A1 Oligodendrocyte cytotoxic factor |
| 03/06/1991 | EP0415219A1 ANF-Antagonist |
| 03/06/1991 | EP0414921A1 Human monoclonal antibody reactive with pseudomonas aeruginosa, cell which produces the antibody, method of production, and pharmaceutical preparation |
| 03/06/1991 | EP0414807A1 Human mammary cell growth inhibitor and methods of production and use |
| 03/06/1991 | EP0414730A1 Luminide and macroluminide class of pharmaceuticals |
| 03/06/1991 | EP0414728A1 NOVEL NEUTROPHIL CHEMOTACTIC FACTOR, CLONED cDNA AND MONOCLONAL ANTIBODIES THERETO |
| 03/06/1991 | CA2024698A1 Peptidyl diflurodiol renin inhibitors |
| 03/06/1991 | CA2024587A1 Drug delivery compositions based on biological cells or components thereof and methods |
| 03/05/1991 | WO1991003570A1 Monoclonal antibody against infectious pancreatic nephrosis virus having neutralizing activity |
| 03/05/1991 | WO1991003487A1 Prodrug derivatives of thyrotropin-releasing hormone (trh) |
| 03/05/1991 | US4997950 Novel C-terminal gastrin antagonists |
| 03/05/1991 | US4997929 Genetic engineering |
| 03/05/1991 | US4997916 Method for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cell |
| 03/05/1991 | US4997915 Purification of pertussis toxins |
| 03/05/1991 | US4997825 Estrogen and growth hormone |
| 03/05/1991 | US4997822 Heterocyclic compounds having a 2-(2-(N,N-bis(2-chloroethyl)-diamidophosphoryloxy) ethyl) radical |
| 03/05/1991 | US4997816 Gonadtrophin |
| 03/05/1991 | US4997815 Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin |
| 03/05/1991 | US4997814 Corticosteroid binding globulin and antiinflammatory agent that binds to it |
| 03/05/1991 | US4997762 Tumor associated monocoloal antibodies derived from human B-cell line |
| 03/05/1991 | US4997648 Bactericide, antiinflammatory, immunosuppressive |
| 03/05/1991 | US4997646 Use of interferons of the alpha family to enhance fertility in mammals |
| 03/05/1991 | US4997645 Administering interferon and dipyridamole |
| 03/05/1991 | US4997644 Ethylene oxide-propylene oxide copolymer |
| 03/05/1991 | CA2066449A1 Prodrug derivatives of thyrotropin-releasing hormone (trh) |
| 03/05/1991 | CA2039168A1 Neutralizing monoclonal antibody to infectious pancreatic necrosis virus |
| 03/05/1991 | CA2023099A1 Amino acid derivatives |
| 03/05/1991 | CA1280987C Antibacterial composition |
| 03/02/1991 | WO1991003492A1 MODIFIED HUMAN ANTI-Rh(D) ANTIBODIES |
| 03/02/1991 | WO1991003260A1 Antisense oligonucleotides to c-abl proto-oncogene |
| 03/02/1991 | CA2065294A1 Antisense oligonucleotides to c-abl proto-oncogene |
| 03/02/1991 | CA2065278A1 Modified human anti-rh(d) antibodies |
| 03/02/1991 | CA2024053A1 Anf-antagonist |
| 03/01/1991 | WO1991003549A1 Light activated acyl-enzymes |
| 03/01/1991 | WO1991003548A1 Superoxide dismutase-catalase conjugates |
| 03/01/1991 | WO1991003488A1 Methods and compositions for healing ulcers |
| 03/01/1991 | CA2065430A1 Superoxide dismutase - catalase conjugates |
| 03/01/1991 | CA2065416A1 Methods and compositions for healing ulcers |
| 03/01/1991 | CA2024171A1 Low-irritative nasal preparation |
| 03/01/1991 | CA2024030A1 Oligodendrocyte cytotoxic factor |
| 03/01/1991 | CA2021408A1 Method for treating hypermotility diseases of the bowel employing an ace inhibitor and formulation for use therein |
| 02/28/1991 | DE3928227A1 Controlling sexual cycle in water and leaf frogs - by injection with follicle stimulating- and luteinising hormones and chorionic gonadotropin |
| 02/27/1991 | EP0414632A2 Cyclosporin derivatives |
| 02/27/1991 | EP0414605A1 Pasty aqueous pharmaceutical compositions |
| 02/27/1991 | EP0414404A2 Process for encapsulation of biologicals |
| 02/27/1991 | EP0414178A2 Non-human primate CD4 polypeptides and human CD4 molecules capable of being glycosylated |
| 02/27/1991 | EP0414080A2 Non-parenteral pharmaceutical compositions for insulin |
| 02/27/1991 | EP0414035A2 Gibbon ape leukemia virus receptor |
| 02/27/1991 | EP0414007A2 A novel arginine deiminase, its manufacturing method and an anti-cancer agent containing this enzyme as an effective ingredient |
| 02/27/1991 | EP0413967A1 Novel antibiotic |
| 02/27/1991 | EP0413957A2 Pulmonary surfactant protein fragments |
| 02/27/1991 | EP0413908A2 Soluble extracellular fragment of the human IFN-beta 2/IL-6 receptor, its preparation and pharmaceutical compositions containing it |
| 02/27/1991 | EP0413839A1 GHRH analogs |
| 02/27/1991 | EP0413818A1 Process for producing a human neutrophil chemotactic factor polypeptide. |
| 02/27/1991 | EP0413794A1 Periodontal and bone regeneration factor, materials and methods |
| 02/27/1991 | EP0413792A1 Products containing a lithium salt and a tumour necrosis factor. |
| 02/27/1991 | EP0413762A1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 02/27/1991 | EP0413750A1 Renin inhibitory peptides containing a substituted phenoxyacetyle group |
| 02/27/1991 | EP0413721A1 Human gm-csf variants |
| 02/27/1991 | EP0413709A1 Fatty amino acids, and homo- and hetero-oligomers and conjugates thereof |
| 02/27/1991 | EP0413687A1 Sequential improved method for treatment of human blood-clotting factor products |
| 02/27/1991 | CN1049519A Pseudorabies virus not occurring in nature and vaccines containing same |
| 02/27/1991 | CN1049505A Peptides having bradykinin-antagonistic action |
| 02/26/1991 | WO1991002799A1 Fusion proteins |
| 02/26/1991 | US4996358 Control, prevention rheumatic diseases |
| 02/26/1991 | US4996299 Method for preparing pertussis toxin toxoid using HcHo and amino acids |
| 02/26/1991 | US4996297 contraceptives for non-rodent mammals |
| 02/26/1991 | US4996194 Activated lymphocytes having increased antigenic activity; for vaccines |
| 02/26/1991 | US4996193 Combined topical and systemic method of administration of cyclosporine |